13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • Please share this website:
    Research home > Beat Cancer Project > New treatment for estrogen sensitive cancers

    New treatment for estrogen sensitive cancers

    Dr Fiona Young

    How new marine drug compounds specifically target cancer cells

    Our research

    A common Australian sea snail has been identified as a source of interesting anti-cancer drug lead compounds. In this project we will test the snail compounds, and related compounds synthesized in the laboratory, against estrogen sensitive cancers. We aim to find out how the anti-cancer agents kill breast cancer cells by collecting all the ‘message’ molecules that the cancer cells make in response to the anticancer agents. This will allow us to identify the specific gene targets that initiate the process of cell death and provide data to design a clinical (human) trial. 

    What we aim to achieve

     We aim to adapt a well-established cell culture model (the ‘E-screen’) for anti-cancer screening in estrogen sensitive cancer cell lines (the Cancer E-Screen). This will enable us to assess the impact of estrogen on the breast cancer cells, which make them divide and grow in culture, in the same sort of way that they do in a woman with cancer. This project will provide the foundation for future development of the snail compounds as therapeutic drugs for the treatment of estrogen sensitive breast cancer.


  • Apply for funding

    Apply for funding

    Find out more about applications for funding.

  • Cancer statistics

    Cancer statistics

    Access the latest cancer statistics for South Australia

  • Clinical trials

    Clinical trials

    Access the list of current clinical trials taking place in South Australia.